Biocon informs about updates

15 Jun 2024 Evaluate

Biocon has informed that the US Food and Drug Administration (USFDA) concluded a GMP inspection of our API facility (Site 6), located at Visakhapatnam, Andhra Pradesh, on 14 June 2024. Three observations were cited at the end of the Inspection, which they will be addressing within the stipulated time. Biocon stands committed to Quality, Safety & Efficacy of the products manufactured. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.


Biocon Share Price

380.70 2.90 (0.77%)
16-Feb-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1703.45
Dr. Reddys Lab 1267.45
Cipla 1357.00
Zydus Lifesciences 910.00
Lupin 2216.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×